125 related articles for article (PubMed ID: 9121075)
1. [Use of corticosteroids and immunoglobulins in acute and chronic immune thrombocytopenia in childhood. A clinically oriented treatment concept].
Höcker-Schulz S; Elstner T; Pawlosky J; Gadner H
Klin Padiatr; 1997; 209(1):30-5. PubMed ID: 9121075
[TBL] [Abstract][Full Text] [Related]
2. Childhood acute immune thrombocytopenic purpura: 20 years later.
Blanchette VS; Carcao M
Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
[TBL] [Abstract][Full Text] [Related]
3. [Introduction of laparoscopic splenectomy for the treatment of immune thrombocytopenic purpura].
Kiudelis M; Endzinas Z; Mickevicius A; Reckauskas M
Zentralbl Chir; 2004 Apr; 129(2):108-13. PubMed ID: 15106041
[TBL] [Abstract][Full Text] [Related]
4. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
Schiavotto C; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
[TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura.
Fujisawa K; Iyori H; Ohkawa H; Konishi S; Bessho F; Shirahata A; Miyazaki S; Akatsuka J;
Int J Hematol; 2000 Oct; 72(3):376-83. PubMed ID: 11185998
[TBL] [Abstract][Full Text] [Related]
6. Evaluating bleeding severity in children with newly diagnosed immune thrombocytopenia: a pilot study.
Pansy J; Minkov M; Dengg R; Quehenberger F; Lackner H; Nebl A; Sovinz P; Schwinger W; Urban C; Benesch M
Klin Padiatr; 2010 Nov; 222(6):374-7. PubMed ID: 21058224
[TBL] [Abstract][Full Text] [Related]
7. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
Schiavotto C; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
[TBL] [Abstract][Full Text] [Related]
8. [Idiopathic thrombocytopenic purpura in childhood: retrospective analysis of the clinical prognosis].
Yamamoto T; Kinoshita T; Miyata H
Rinsho Ketsueki; 1993 Nov; 34(11):1445-51. PubMed ID: 8254906
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy.
Duru F; Fisgin T; Yarali N; Kara A
Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of acute immune thrombocytopenic purpura in children--intravenous immunoglobulin or treatment with corticosteroids?].
Masłowska E; Wysocki M; Michalak-Nowaczyk A
Pediatr Pol; 1996 Jan; 71(1):25-9. PubMed ID: 8966063
[TBL] [Abstract][Full Text] [Related]
11. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment.
Dickerhoff R; von Ruecker A
J Pediatr; 2000 Nov; 137(5):629-32. PubMed ID: 11060527
[TBL] [Abstract][Full Text] [Related]
12. [Effects of maintenance treatment after high-dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura].
Yasunaga K; Kokawa T; Fujitake H; Nomura S; Kageyama T; Ohyabu H; Tatsumi N; Im T; Park K; Kawagoe H
Rinsho Ketsueki; 1991 Sep; 32(9):938-44. PubMed ID: 1719256
[TBL] [Abstract][Full Text] [Related]
13. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.
Dan K; Gomi S; Kuramoto A; Maekawa T; Nomura T
Int J Hematol; 1992 Jun; 55(3):287-92. PubMed ID: 1498319
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
[TBL] [Abstract][Full Text] [Related]
15. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
16. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
17. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
Erduran E; Aslan Y; Gedik Y; Orhan F
Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
[TBL] [Abstract][Full Text] [Related]
18. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
Gereige RS; Barrios NJ
P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
[TBL] [Abstract][Full Text] [Related]
19. Outcome of children with idiopathic thrombocytopenic purpura, based on original material.
Zawitkowska-Klaczyńska J; Nurzyńska-Flak J; Kattski K; Kowalczyk JR
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):194-7. PubMed ID: 16146076
[TBL] [Abstract][Full Text] [Related]
20. [Course of the disease in relation to the therapy in idiopathic thrombocytopenic purpura in childhood].
Schmitt HJ; Eckstein K; Gutjahr P
Klin Padiatr; 1985; 197(5):419-22. PubMed ID: 4068601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
